Connect Sign In
Pathologists at ARUP routinely help flesh out complex reports by phone or email and actively engage with medical practitioners, and sometimes patients.
The American Board of Internal Medicine Foundation recently released a list of its “Top 12” Choosing Wisely recommendations. It based the rankings on evidence of success.
ARUP recently rolled out their next generation UM dashboard for clients hospitals and healthcare organizations that will allow them to mine data and make it actionable.
Last week, the ECRI Institute released its top 10 list of patient safety concerns for 2018. At the top of the list for the first time ever was diagnostic error.
The Centers for Medicare & Medicaid Services published proposed Clinical Laboratory Fee Schedule. The rates outlined in the CFLS do not reflect the true cost or value of clinical lab services.
A number of studies reveal that 10–30% of laboratory tests performed in the United States are either unnecessary or inappropriate. A new report has guidelines for lab stewardship for test orders.
Confusion about lab test accuracy is not uncommon, even among medical professionals. Much of it stems from a misunderstanding of the relationship between sensitivity and specificity.
By avoiding unnecessary testing, patients and healthcare organizations can save money while still providing quality patient care.
Laboratory testing is the highest-volume medical activity, so reducing unnecessary testing has an impact on the outcomes and efficiency of a patient’s care.
A recent study showed that an estimated 30% of all laboratory tests run across the healthcare continuum were unnecessary. That means roughly 2.1 billion unnecessary lab tests are performed each year.
Doctors need easy access to testing guidance, nudges toward evidence-based testing, and professional feedback when they deviate from recommended patterns.
ARUP provides an extensive menu of toxicology testing, encompassing pain management, illicit drugs, neonatal drug testing, and therapeutic drug monitoring.
